Apis Capital Advisors, LLC holds a focused book of 60 reported positions worth $1.0B as of Q2 2026 (disclosed Aug 14, 2026, a ~45-day 13F lag). This quarter First Tracks Biotherapeutics first appears in 13F filings (one of 2 new listings in the book), a listing rather than a purchase; they opened Oceanagold Corp and trimmed Silicon Motion Technol-ADR. Their largest long position is Garrett Motion Inc at 10% of the reported non-option book. Cloning the disclosed picks since 2015 would be +445% (+15.8%/yr). That is a simulation of the disclosed long book, not audited returns.
Following at the filing date actually beat the quarter-end book by 34.8 points over this window.
Growth of $10,000 cloning Apis Capital Advisors, LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~45 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
+4 sectors below the cut, 2% together
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as Apis Capital Advisors, LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| Maple Rock Capital Partners Inc. | 7 / 60 | $1.4B |
| MPM BioImpact LLC | 6 / 60 | $456.7M |
| Potrero Capital Research LLC | 6 / 60 | $34.5M |
| Eversept Partners, LP | 7 / 60 | $335.3M |
| Exchange Traded Concepts, LLC | 17 / 60 | $3.8B |
| Maytree Asset Management Ltd | 6 / 60 | $26.4M |
| Act Capital Management, LLC | 6 / 60 | $25.9M |
| Rakuten Securities, Inc. | 15 / 60 | $64.0M |
Ranked by the share of each fund's own book sitting in the names it shares with Apis Capital Advisors, LLC: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Garrett Motion Inc COM | $98.8M | 2.73M | 9.6% | ▲+2.4% Added · +63K sh | |
| 2 | Silicon Motion Technology Co SPONSORED ADR | $59.5M | 178.4K | 5.8% | ▼−28% Reduced · −71K sh | |
| 3 | Celcuity Inc COM | $56.3M | 538.0K | 5.5% | ▲+4.5% Added · +23K sh | |
| 4 | Aris Mining Corporation COM | $53.4M | 2.52M | 5.2% | ▲+0.2% Added · +6K sh | |
| 5 | Oceanagold Corp COM NEW | $45.1M | 1.27M | 4.4% | ▲New New position | |
| 6 | Sandisk Corp COM | $43.2M | 19.0K | 4.2% | ▼−61% Reduced · −30K sh | |
| 7 | SSR Mining In COM | $39.9M | 1.41M | 3.9% | ▲+1.1% Added · +16K sh | |
| 8 | Western Digital Corp COM | $37.0M | 58.0K | 3.6% | ▼−47% Reduced · −52K sh | |
| 9 | Seagate Technology HLDNGS PL ORD SHS | $34.3M | 35.6K | 3.3% | ▼−40% Reduced · −24K sh | |
| 10 | Anaptysbio Inc COM | $33.5M | 497.0K | 3.3% | ▲+109% Added · +259K sh | |
| 11 | Hinge Health Inc CL A | $30.9M | 372.0K | 3.0% | ▲+76% Added · +161K sh | |
| 12 | Talen Energy Corp COM | $30.0M | 78.0K | 2.9% | ▼−2.5% Reduced · −2K sh | |
| 13 | Brookdale SR Living Inc COM | $29.9M | 1.86M | 2.9% | ▲+90% Added · +880K sh | |
| 14 | Sharkninja Inc COM SHS | $29.5M | 194.0K | 2.9% | ▲+13% Added · +23K sh | |
| 15 | Unity Software Inc COM | $28.6M | 1.00M | 2.8% | ▲New New position | |
| 16 | Nokia Corp SPONSORED ADR | $27.7M | 2.09M | 2.7% | ▲New New position | |
| 17 | Cleveland-Cliffs Inc New COM | $23.9M | 2.54M | 2.3% | ▲New New position | |
| 18 | Vista Energy S.A.B. De C.V. SPONSORED ADS | $23.6M | 370.5K | 2.3% | ▲+61% Added · +141K sh | |
| 19 | Cellebrite Di Ltd ORDINARY SHARES | $21.5M | 1.47M | 2.1% | ▲+6.5% Added · +90K sh | |
| 20 | Turning PT Brands Inc COM | $20.9M | 246.6K | 2.0% | ▼−2.9% Reduced · −7K sh | |
| 21 | Nlight Inc COM | $19.0M | 273.2K | 1.9% | ▼−17% Reduced · −57K sh | |
| 22 | Toast Inc CL A | $18.4M | 662.0K | 1.8% | ▲+5.1% Added · +32K sh | |
| 23 | On Semiconductor Corp COM | $17.4M | 184.0K | 1.7% | ▼−7.1% Reduced · −14K sh | |
| 24 | Vishay Intertechnology Inc COM | $14.6M | 271.0K | 1.4% | ▲New New position | |
| 25 | Sitime Corp COM | $13.0M | 17.4K | 1.3% | ▼−36% Reduced · −10K sh | |
| 26 | Riot Platforms Inc COM | $12.3M | 450.0K | 1.2% | ▲New New position | |
| 27 | Syndax Pharmaceuticals Inc COM | $12.2M | 556.0K | 1.2% | ▲+1.1% Added · +6K sh | |
| 28 | Liquidia Corporation COM NEW | $11.2M | 140.0K | 1.1% | ▼−53% Reduced · −156K sh | |
| 29 | Oruka Therapeutics Inc COM | $10.7M | 112.0K | 1.0% | ▲New New position | |
| 30 | Abivax Sa SPONSORED ADS | $9.9M | 74.0K | 1.0% | ▼−43% Reduced · −55K sh | |
| 31 | Alpha & Omega Semiconductor SHS | $9.8M | 206.3K | 1.0% | ▲New New position | |
| 32 | Addus Homecare Corp COM | $8.4M | 84.0K | 0.8% | ▲+6.3% Added · +5K sh | |
| 33 | Calumet Inc COM | $8.4M | 232.0K | 0.8% | ▲New New position | |
| 34 | Ambarella Inc SHS | $7.6M | 88.0K | 0.7% | ▲New New position | |
| 35 | Viavi Solutions Inc COM | $7.1M | 148.0K | 0.7% | ▲New New position | |
| 36 | Ecovyst Inc COM | $6.7M | 540.0K | 0.7% | ▲New New position | |
| 37 | Frequency Electrs Inc COM | $6.6M | 99.7K | 0.6% | ▲+16% Added · +14K sh | |
| 38 | Travere Therapeutics Inc COM | $6.4M | 112.0K | 0.6% | ▲New New position | |
| 39 | Palvella Therapeutics Inc Ne COM | $6.0M | 39.0K | 0.6% | ▼−56% Reduced · −50K sh | |
| 40 | Wolfspeed Inc COMMON STOCK | $5.6M | 116.0K | 0.5% | ▲New New position | |
| 41 | Semtech Corp COM | $4.9M | 30.0K | 0.5% | ▲New New position | |
| 42 | Lightpath Technologies Inc COM CL A | $4.8M | 292.0K | 0.5% | ▲+5.8% Added · +16K sh | |
| 43 | Almonty Inds Inc COM NEW | $4.6M | 278.0K | 0.4% | ▲+16% Added · +38K sh | |
| 44 | First Tracks Biotherapeutics ORD SHS | $4.5M | 226.0K | 0.4% | →Listed Newly reportable | |
| 45 | Aeluma Inc COM | $4.3M | 194.0K | 0.4% | ▼−5.8% Reduced · −12K sh | |
| 46 | Hallador Energy Company COM | $3.5M | 200.0K | 0.3% | ▼−76% Reduced · −639K sh | |
| 47 | Enphase Energy Inc COM | $3.4M | 70.0K | 0.3% | ▲New New position | |
| 48 | Flotek Industries Inc COM NEW | $3.2M | 138.0K | 0.3% | ▲New New position | |
| 49 | Silicom Ltd ORD | $2.1M | 44.0K | 0.2% | ▲New New position | |
| 50 | Kopin Corp COM | $1.8M | 400.0K | 0.2% | ▲New New position |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1386892/holdings"
Use Arkolith to show APIS CAPITAL ADVISORS, LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 14, 2026 | 45d | 60 | $1.0B | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 45d | 52 | $648.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 48d | 43 | $573.9M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 45d | 49 | $452.7M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 | 44d | 42 | $281.5M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 45d | 42 | $206.8M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 45d | 29 | $150.1M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 45d | 33 | $143.7M | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 45d | 36 | $135.5M | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 45d | 36 | $131.8M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 45d | 27 | $95.4M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 | 44d | 23 | $77.1M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 11, 2023 | 42d | 30 | $99.1M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 12, 2023 | 42d | 24 | $93.9M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 45d | 27 | $86.3M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 45d | 25 | $66.6M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 | 43d | 29 | $88.7M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 | 43d | 30 | $82.6M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 45d | 22 | $90.3M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 | 43d | 37 | $105.0M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 47d | 36 | $116.2M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 | 44d | 43 | $110.1M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 47d | 38 | $103.4M | 13F-HR |
| Q3 2019 | Sep 30, 2019 | Nov 14, 2019 | 45d | 27 | $63.8M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.